Based on my research from Finviz and Yahoo Finance, here are today's top trending stocks and the reasons for their movements: ## Top Trending Stocks Today (June 12, 2026) ### 1. **GELS (Gelteq Ltd)** - **+80%+** - **Why it's moving**: Gelteq announced the establishment of a Center of Excellence in China to accelerate product development and commercial expansion. The company also recently commenced a veterinary medicine clinical trial to support an FDA regulatory pathway and announced positive preclinical results showing increased medicinal cannabinoid absorption using its oral gel delivery platform. ### 2. **PPCB (Propanc Biopharma)** - **+80%** - **Why it's moving**: The stock surged after the company authorized a $5.0 million share repurchase program. Additionally, the CEO attended a keynote address on "Rejuvenation and Health: Science for an Ageing Society" at the University of Granada, Spain, and the company recently implemented a reverse stock split to support continued Nasdaq listing and growth plans. ### 3. **QH (Quhuo Ltd ADR)** - **+Significant gains** - **Why it's moving**: Quhuo is a Chinese workforce operational solution platform company showing strong performance with notable institutional ownership changes. ### 4. **GLXG (Galaxy Payroll Group Ltd)** - **+Significant gains** - **Why it's moving**: The company recently renewed a five-year strategic cooperation agreement with NIKE China Holding HK Limited and has been working on integrating AI and stablecoin technology in HR solutions through partnerships. ### 5. **Other Notable Movers**: - **SPCE (Virgin Galactic)** - +21.66% - **RKLB (Rocket Lab)** - +9.26% - **BTC-USD (Bitcoin)** - +0.95% ## Market Context The overall market shows mixed sentiment with some tech stocks declining (Adobe -6.25%) while others in the space exploration and cryptocurrency sectors are gaining. The top gainers are primarily small-cap biotech and specialty pharmaceutical companies with recent positive news catalysts. **Note**: These movements are based on real-time data from Finviz and Yahoo Finance as of June 12, 2026. The gains are particularly pronounced in small-cap biotech stocks with recent FDA-related news or strategic partnerships.